1-3 of 3
Authors: E. Rosenthal
Sort by
Journal Article
HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007–12: impact on susceptibility to first-line strategies
Get access
Pierre Frange and others
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 7, July 2015, Pages 2084–2089, https://doi.org/10.1093/jac/dkv049
Published: 26 February 2015
Journal Article
Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial
Get access
Charlotte Charpentier and others
Journal of Antimicrobial Chemotherapy, Volume 68, Issue 3, March 2013, Pages 690–696, https://doi.org/10.1093/jac/dks455
Published: 14 November 2012
Journal Article
Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial)
Get access
Sébastien Gallien and others
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 1, January 2011, Pages 184–191, https://doi.org/10.1093/jac/dkq395
Published: 28 October 2010
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals